1.29
Lineage Cell Therapeutics Inc Aktie (LCTX) Neueste Nachrichten
Promising Penny Stocks To Consider In May 2026 - simplywall.st
Lineage Cell Therapeutics (LCTX) price target increased by 14.58% to 5.61 - MSN
Lineage reports positive 36-month findings on GA cell therapy - Eyes On Eyecare
Earnings Preview: LCTX to Report Financial Results Post-market on May 12 - Moomoo
Cell-Based Therapies Poised to Disrupt Multi-Billion-Dollar Anti-Aging and Neurodegenerative Markets - Investing News Network
Lineage Cell Therapeutics, Inc. Common Stock (NY: LCTX - FinancialContent
Lineage Cell Therapeutics, Inc. Common Stock (NYSE:LCTX) Stock Quote - FinancialContent
Lineage Cell Therapeutics Q1 Earnings Call Highlights - sharewise.com
Lineage Cell Therapeutics Q1 2026 earnings preview - MSN
Lineage Cell Therapeutics featured in European Pharmaceutical Review report on scalable cell therapies - Traders Union
Lineage Cell Therapeutics (LCTX) Returns To Loss In Q1 2026 Challenging Profitability Narratives - Sahm
Lineage Cell Therapeutics Highlights R&D Momentum Amid Losses - TipRanks
Q1 2026 Lineage Cell Therapeutics Inc Earnings Call Transcript - GuruFocus
Lineage Cell Therapeutics, Inc. (AMEX:LCTX) Q1 2026 Earnings Call Transcript - Insider Monkey
Lineage targets operations into Q2 2028 as it launches COR1 and scales ILT1 manufacturing - MSN
Lineage Cell (LCTX) reports Q1 loss, lags revenue estimates - MSN
Lineage Cell Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update - BioSpace
Lineage Cell Therapeutics (LCTX) Reports Q1 2026 Earnings and St - GuruFocus
TradingKey - TradingKey
Lineage Cell Therapeutics Inc (LCTX) Q1 2026 Earnings Call Highl - GuruFocus
Lineage Cell Therapeutics (LCTX) Reports Q1 Results and Advancem - GuruFocus
Is Lineage Cell Therapeutics (LCTX) Overvalued After Q1 2026 EPS - GuruFocus
Lineage Cell (LCTX) Receives Funding to Support Operations Throu - GuruFocus
LCTX: Pipeline expansion, manufacturing progress, and strong cash runway drive 2026 outlook - TradingView
LCTX: Strong pipeline expansion and robust cash position support continued clinical and manufacturing progress - TradingView
Lineage Cell (LCTX) Reports Q1 Loss, Lags Revenue Estimates - Yahoo Finance
Lineage Cell Therapeutics holds investor call after releasing first quarter 2026 results - Traders Union
LCTX: Positive clinical results, pipeline expansion, and strong cash position highlight Q1 2026 - TradingView
Lineage Cell Therapeutics (NYSE: LCTX) reports higher Q1 2026 revenue and continued R&D spend - Stock Titan
Lineage Cell Therapeutics (LCTX) posts Q1 2026 results and advances cell therapy pipeline - Stock Titan
Lineage Cell: Q1 Earnings Snapshot - WKYC
Lineage Cell Therapeutics Inc (LCTX) Q1 2026 Earnings Call Highlights: Strategic Advances and ... By GuruFocus - Investing.com Canada
MSN Money - MSN
Why Lineage (LCTX) might be the best kept secret in the market (+2.55%) 2026-05-11Post Earnings - Newser
Lineage Cell Therapeutics, Inc. (LCTX) Presents at FFB Retinal Therapeutics Innovation SummitSlideshow - Seeking Alpha
Lineage Cell Therapeutics to Report First Quarter 2026 Financial Results and Provide Business Update on May 12, 2026 - BioSpace
Lineage Cell Therapeutics to Report First Quarter 2026 Financial Results and Provide Business Update - PharmiWeb.com
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) - Weekly Voice
CCORF Initiates Lineage Cell Therapeutics(LCTX.US) With Buy Rating, Announces Target Price $9 - Moomoo
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):